Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > TLT will be very busy for a very long time...

View:

Post by wildbird1 on Dec 13, 2024 12:53pm

TLT will be very busy for a very long time...

The biggest advantages of TLT treatment.
1) High efficacy and high duration of response.
2)100% safe.
3) Because of its Mechanism Of Action, TLT treatment will be able to treat almost 100% of cancer type.

How many type of cancer are there?
In this link....Types of Cancer | What Are The Different Types of Cancer | ACRF
It said that there is over 200 different type of cancer.

The above could keep TLT very buzy for a very long time(and at the same time, making all the longs on this board very rich).

I love my TLT shares.
.

301

Comment

Comment by Tapps21 on Dec 13, 2024 1:42pm

It would be a dream come true Wildbird, if Thealases ACT was recognized for its true potential. The question is why is something that seems to be changing the way cancer treatment is provided and The longevity of response is taking so long to get the go ahead. Frustrating to say the least. Good things come to those who wait, I guess.

181

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password